Harry Marfatia serves as an executive at Telix Pharmaceuticals Limited, overseeing strategic initiatives and leadership responsibilities.
| Company | Designation | Period |
|---|---|---|
| Futuris Automotive | Group Finance Analyst | Jun 2012 – Aug 2013 |
| Telix Pharmaceuticals Limited | Director Corporate Finance (Global) | Jan 2020 – May 2021 |
| Origin Energy | Management Accountant | Jan 2004 – Jan 2007 |
| Telstra | Financial Controller | Feb 2017 – Dec 2019 |
| Telstra | Group Finance Manager | Feb 2015 – Apr 2017 |
| Southern Cross Computer Systems | Group Finance Manager | Aug 2013 – Feb 2015 |
| IBM | Senior Financial Analyst | Aug 2007 – Jun 2012 |
| Telix Pharmaceuticals Limited | Chief Financial Officer - APAC | May 2021 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Telix Pharmaceuticals Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Harry Marfatia's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Telix Pharmaceuticals Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)